SEOM clinical guidelines on cardiovascular toxicity (2018)
| Autor: | Ana Santaballa, Almudena Garcia, Carmen Beato, Teresa López Fernández, Joaquín Gavilá, J. A. Virizuela, S. de la Cruz, R. Andres, R. de las Peñas, Santiago González-Santiago |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Cancer Research medicine.medical_specialty Cardiotonic Agents Side effect MEDLINE Clinical Guides in Oncology Antineoplastic Agents Disease 03 medical and health sciences 0302 clinical medicine Neoplasms Medicine Humans Chemotherapy Disease management (health) Intensive care medicine Societies Medical Risk assessment Cancer Cardiotoxicity Clinical Trials as Topic business.industry Disease Management Early detection General Medicine Guideline medicine.disease Prognosis 030104 developmental biology Oncology Cardiovascular Diseases 030220 oncology & carcinogenesis Practice Guidelines as Topic business |
| Zdroj: | CLINICAL & TRANSLATIONAL ONCOLOGY r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname Clinical & Translational Oncology r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón |
| ISSN: | 1699-048X |
| Popis: | One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor's prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM's ongoing commitment to progressing and improving supportive care for cancer patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink